TNF and obstructive sleep apnea syndrome: As evidence for a causal role of OSA-related cHPX in such plasma CySS increases, we found significant decreases in CySS with CPAP treatment in the cHPX group, notably, at unchanged BMI and other vascular risk factors including glycemic marker, plasma lipids, homocysteine, and circulating TNF.